Under the gun for Cohen deal, Novartis CEO Vas Narasimhan hits the brakes on US drug price...

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Jul 18, 2018 at 9:42 AM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,746
    Likes Received:
    3
    via President Donald Trump may not be getting the cascading drug prices he promised, but he is holding the line against any increases — at least for this year.

    Novartis CEO Vas Narasimhan today joined Pfizer CEO Ian Read in promising to put the brake on US drug price hikes. And that will add to the pressure on the rest of the major players to do the same.

    article source